Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|June 9, 2023
Adipokines and risk of rheumatoid arthritis: A two-sample multivariable Mendelian randomisation studyGeorgios K Vasileiadis, Sergi Sayols, Sizheng Steven Zhao, et al.
Frontiers in Immunology|July 6, 2019
The Rheumatoid Arthritis Risk Gene AIRE Is Induced by Cytokines in Fibroblast-Like Synoviocytes and Augments the Pro-inflammatory ResponseBeatrice Bergström, Christina Lundqvist, Georgios K Vasileiadis, et al.
Biomolecules|March 6, 2021
Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of InflammationGeorgios K Vasileiadis, Anna-Carin Lundell, Yuan Zhang, et al.
Immunologic Research|August 11, 2019
On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cellsGeorgios Ntolkeras, Chrysanthi Barba, Athanasios Mavropoulos, et al.
Auto- Immunity Highlights|November 12, 2018
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?Georgios K Vasileiadis, Efthymios Dardiotis, Athanasios Mavropoulos, et al.
Frontiers in Immunology|February 18, 2021
Recombinant Adiponectin Induces the Production of Pro-Inflammatory Chemokines and Cytokines in Circulating Mononuclear Cells and Fibroblast-Like Synoviocytes From Non-Inflamed SubjectsYuan Zhang, Jonathan Aldridge, Georgios K Vasileiadis, et al.
ACR Open Rheumatology|November 4, 2024
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid ArthritisGeorgios K Vasileiadis, Yuan Zhang, Tahzeeb Fatima, et al.
Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.
Journal of Translational Autoimmunity|September 2, 2025
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprintGeorgios K Vasileiadis, Yuan Zhang, Marion Laudette, et al.
RMD Open|April 5, 2024
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR studyVioletta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, et al.
Pageof 1